Midega, T.D.; Chaves, R.C.F.; Ashihara, C.; Alencar, R.M.; Queiroz,V.N.F.; Zelezoglo, G.R.; Vilanova, L.C.D.S.; Olivato, G.B.; Cordioli, R.L.; Bravim, B.A.; Corrêa, T.D. Ketamine use in critically ill patients: a narrative review. Rev. Bras. Ter. Intensiva 2022, 34(2), 287-294. DOI: 10.5935/0103-507X.20220027-pt.
DOI: https://doi.org/10.5935/0103-507X.20220027-en
Bohatyrewicz, M.; Dudek, M.; Rak, M. Ketalicja w krainie czarów. In Polowanie na goryle… czyli nieoczywista medycyna ratunkowa; PZWL Wydawnictwo lekarskie, Polska, 2019; 211-234, ISBN 978-83-200-5843-7.
Hirota, K.; Lambert, D.G. Ketamine; history and role in anesthetic pharmacology. Neuropharmacology 2022, 216, Art. No: 109171. DOI: 10.1016/j.neuropharm.2022.109171.
DOI: https://doi.org/10.1016/j.neuropharm.2022.109171
Zastosowanie ketaminy na oddziale intensywnej terapii (OIT). Available online: https://intensywna.pl/zastosowanie-ketaminy-na-oddziale-intensywnej-terapii-oit/ (accessed on 29.06.2024).
Voss, L.J.; Harvey, M.G.; Sleigh, J.W. Non-NMDA Mechanisms of Analgesia in Ketamine Analogs. Front. Pain Res. (Lausanne) 2022, 3, Art. No: 827372. DOI: 10.3389/fpain.2022.827372.
DOI: https://doi.org/10.3389/fpain.2022.827372
Feeney, A.; Papakostas, G.I. Pharmacotherapy: Ketamine and Esketamine. Psychiatr. Clin. North Am. 2023, 46(2), 277-290. DOI: 10.1016/j.psc.2023.02.003.
DOI: https://doi.org/10.1016/j.psc.2023.02.003
Thanapaisal S.; Oatts J.; Zhao J.; Perez C.I.; Yang Y.; Porco T.C.; Singh K.; Han Y. Effect of general anaesthesia on intraocular pressure in paediatric patients: a systematic review. Eye 2021, 35, 1205–1212. DOI: https://doi.org/10.1038/s41433-020-1093-8.
DOI: https://doi.org/10.1038/s41433-020-1093-8
Silverstein, W.K.; Juurlink, D.N.;, Zipursky, J.S.; Ketamine for the treatment of acute pain. CMAJ 2021, 193(43), Art. No: E1663. DOI: 10.1503/cmaj.210878.
DOI: https://doi.org/10.1503/cmaj.210878
Update from the K-hole. Available online: https://emottawablog.com/2018/07/update-from-the-k-hole-ketamine-in-the-ed/ (accessed on 29.06.2024).
Zanza, C.; Piccolella, F.; Racca, F.; Romenskaya, T.; Longhitano, Y.; Franceschi, F.; Savioli, G.; Bertozzi, G.; De Simone, S.; Cipolloni, L.; La Russa, R. Ketamine in Acute Brain Injury: Current Opinion Following Cerebral Circulation and Electrical Activity. Healthcare (Basel) 2022, 10(3), Art. No: 566. DOI: 10.3390/healthcare10030566.
DOI: https://doi.org/10.3390/healthcare10030566
Dengler, B.A.; Karam, O.; Barthol, C.A.; Chance, A.; Snider, L.E.; Mundy, C.M.; Bounajem, M.T.; Johnson, W.C.; Maita, M.M.; Mendez-Gomez, P.M.; Seifi, A.; Hafeez, S. Ketamine Boluses Are Associated with a Reduction in Intracranial Pressure and an Increase in Cerebral Perfusion Pressure: A Retrospective Observational Study of Patients with Severe Traumatic Brain Injury. Crit. Care Res. Pract. 2022, 2022, Art. No: 834165. DOI: 10.1155/2022/3834165.
DOI: https://doi.org/10.1155/2022/3834165
Laws, J.C.; Vance, E.H.; Betters, K.A.; Anderson, J.J.; Fleishman, S.; Bonfield, C.M.; Wellons, J.C.; Xu, M.; Slaughter, J.C.; Giuse, D.A.; Patel, N.; Jordan, L.C.; Wolf, M.S. Acute Effects of Ketamine on Intracranial Pressure in Children With Severe Traumatic Brain Injury. Crit. Care Med. 2023, 51(5), 563-572. DOI: 10.1097/CCM.0000000000005806.
DOI: https://doi.org/10.1097/CCM.0000000000005806
Mazandi, V.M.; Lang, S.S.; Rahman, R.K.; Nishisaki, A.; Beaulieu, F.; Zhang, B.; Griffis, H.; Tucker, A.M.; Storm, P.B.; Heuer, G.G.; Gajjar, A.A.; Ampah, S.B.; Kirschen, M.P.; Topjian, A.A.; Yuan, I.; Francoeur, C.; Kilbaugh, T.J.; Huh, J.W. Co-administration of Ketamine in Pediatric Patients with Neurologic Conditions at Risk for Intracranial Hypertension. Neurocrit. Care 2023, 38(2), 242-253. DOI: 10.1007/s12028-022-01611-2.
DOI: https://doi.org/10.1007/s12028-022-01611-2
Motov, S.M.; Vlasica, K.; Middlebrook, I.; LaPietra, A. Pain management in the emergency department: a clinical review. Clin. Exp. Emerg. Med. 2021, 8(4), 268-278. DOI: 10.15441/ceem.21.161.
DOI: https://doi.org/10.15441/ceem.21.161
Riccardi, A.; Guarino, M.; Serra, S.; Spampinato, M.D.; Vanni, S.; Shiffer, D.; Voza, A.; Fabbri, A.; De Iaco, F. Study and Research Center of the Italian Society of Emergency Medicine. Narrative Review: Low-Dose Ketamine for Pain Management. J. Clin. Med. 2023, 12(9), Art. No: 3256. DOI: 10.3390/jcm12093256.
DOI: https://doi.org/10.3390/jcm12093256
Parvizrad, R.; Nikfar, S. Low-dose ketamine as an analgesic agent in the emergency department: Efficacy and safety. J. Family Med. Prim. Care 2022, 11(10), 6464-6471. DOI: 10.4103/jfmpc.jfmpc_511_22.
DOI: https://doi.org/10.4103/jfmpc.jfmpc_511_22
Torres, A.C.; Bebarta, V.S.; April, M.D.; Maddry, J.K.; Herson, P.S.; Bebarta, E.K.; Schauer, S. Ketamine Administration in Prehospital Combat Injured Patients With Traumatic Brain Injury: A 10-Year Report of Survival. Cureus 2020, 12(7), Art. No: e9248. DOI: 10.7759/cureus.9248.
DOI: https://doi.org/10.7759/cureus.9248
Ying, M.; Zuo, Y. Efficacy of Low-dose Ketamine for Control of Acute Pain in the Emergency Setting: A Systematic Review and Meta-analysis of Randomized Controlled Trials. West J. Emerg. Med. 2023, 24(3), 644-653. DOI: 10.5811/westjem.2023.2.58368.
DOI: https://doi.org/10.5811/WESTJEM.58368
Shi, X.; Zhou, J.; Jiang, H.; Xie, K. Ketamine in the Management of Acute Pain: A Comprehensive Meta-Analysis. J. Coll. Physicians Surg. Pak. 2024, 34(1), 78-85. DOI: 10.29271/jcpsp.2024.01.78.
DOI: https://doi.org/10.29271/jcpsp.2024.01.78
Altirkistani, B.A; Ashqar, A.A.; Bahathiq, D.M.; Bougis, S.M.; Aljabri, A.M.; Hanafi, S. The Effectiveness of Ketamine Versus Opioids in Patients With Acute Pain in the Emergency Department: A Systematic Review and Meta-Analysis. Cureus 2023, 15(3), Art. No: e36250. DOI: 10.7759/cureus.36250.
DOI: https://doi.org/10.7759/cureus.36250
Jiao, J.; Fan, J.; Zhang, Y.; Chen, L. Efficacy and Safety of Ketamine to Treat Cancer Pain in Adult Patients: A Systematic Review. J. Pain Symptom Manage. 2024, 67(3), e185-e210. DOI: 10.1016/j.jpainsymman.2023.11.004.
DOI: https://doi.org/10.1016/j.jpainsymman.2023.11.004
Orhurhu, V.J.; Robert, J.S.; Ly, N.; Cohen, S. P. Ketamine in Acute and Chronic Pain Management. In StatPearls; StatPearls Publishing; Internet, 2024. Available online: https://www.ncbi.nlm.nih.gov/books/NBK539824/ (accessed on 29.06.2024).
Prescott, M.G.; Iakovleva, E.; Simpson, M.R.; Pedersen, S.A.; Munblit, D.; Vallersnes, O.M.; Austad, B. Intranasal analgesia for acute moderate to severe pain in children - a systematic review and meta-analysis. BMC Pediatr. 2023, 23(1), Art. No: 405. DOI: 10.1186/s12887-023-04203-x.
DOI: https://doi.org/10.1186/s12887-023-04203-x
Almodibeg, B.; Forget, P. Challenges of acute pain management in older patients. Age Ageing 2024, 53(4), Art. No: afae061. DOI: 10.1093/ageing/afae061.
DOI: https://doi.org/10.1093/ageing/afae061
Kunkel, S.; Lenz, T. Hemodynamics in Helicopter Emergency Medical Services (HEMS) Patients Undergoing Rapid Sequence Intubation With Etomidate or Ketamine. J. Emerg. Med. 2022, 62(2), 163-170. DOI: 10.1016/j.jemermed.2021.10.004.
DOI: https://doi.org/10.1016/j.jemermed.2021.10.004
Kim, J.; Jung, K.; Moon, J.; Kwon, J.; Kang, B.H.; Yoo, J.; Song, S.; Bang, E.; Kim, S.; Huh, Y. Ketamine versus etomidate for rapid sequence intubation in patients with trauma: a retrospective study in a level 1 trauma center in Korea. BMC Emerg. Med. 2023, 23(1), Art. No: 57. DOI: 10.1186/s12873-023-00833-7.
DOI: https://doi.org/10.1186/s12873-023-00833-7
Stanke, L.; Nakajima, S.; Zimmerman, L.H.; Collopy, K.; Fales, C.; Powers, W. 4th. Hemodynamic Effects of Ketamine Versus Etomidate for Prehospital Rapid Sequence Intubation. Air Med. J. 2021, 40(5), 312-316. DOI: 10.1016/j.amj.2021.05.009.
DOI: https://doi.org/10.1016/j.amj.2021.05.009
Sharda, S.C.; Bhatia, M.S. Etomidate Compared to Ketamine for Induction during Rapid Sequence Intubation: A Systematic Review and Meta-analysis. Indian J. Crit. Care Med. 2022, 26(1), 108-113. DOI: 10.5005/jp-journals-10071-24086.
DOI: https://doi.org/10.5005/jp-journals-10071-24086
Sharif, S.; Kang, J.; Sadeghirad, B.; Rizv,i F.; Forestell, B.; Greer, A.; Hewitt, M.; Fernando, S.M.; Mehta, S.; Eltorki, M.; Siemieniuk, R.; Duffett, M.; Bhatt, M.; Burry, L.; Perry, J.J.; Petrosoniak, A.; Pandharipande, P.; Welsford, M.; Rochwerg, B. Pharmacological agents for procedural sedation and analgesia in the emergency department and intensive care unit: a systematic review and network meta-analysis of randomised trials. Br. J. Anaesth. 2024, 132(3), 491-506. DOI: 10.1016/j.bja.2023.11.050.
DOI: https://doi.org/10.1016/j.bja.2023.11.050
Zaki, H.A.; Ibrahim, T.; Osman, A.; Elnabawy, W.A.; Gebril, A.; Hamdi, A.H.; Mohamed, E.H. Comparing the Safety and Effectiveness of Ketamine Versus Benzodiazepine/Opioid Combination for Procedural Sedation in Emergency Medicine: A Comprehensive Review and Meta-Analysis. Cureus 2023, 15(3), Art. No: e36742. DOI: 10.7759/cureus.36742.
DOI: https://doi.org/10.7759/cureus.36742
Zaki, H.A.; Shallik, N.; Shaban, E.; Bashir, K.; Iftikhar, H.; Mohamed Khair, Y.; Abdelrahim, M.G.; Fayed, M.; Hendy, M.; Salem, E.E.; Elmoheen, A. An Analytical Comparison Between Ketamine Alone and a Combination of Ketamine and Propofol (Ketofol) for Procedural Sedation and Analgesia From an Emergency Perspective: A Systematic Review and Meta-Analysis. Cureus 2022, 14(7), Art. No: e27318. DOI: 10.7759/cureus.27318.
DOI: https://doi.org/10.7759/cureus.27318
Choi, E.J.; Kim, C.H.; Yoon, J.Y.; Kim, E.J. Ketamine-propofol (ketofol) in procedural sedation: a narrative review. J. Dent. Anesth. Pain Med. 2023, 23(3), 123-133. DOI: 10.17245/jdapm.2023.23.3.123.
DOI: https://doi.org/10.17245/jdapm.2023.23.3.123
Maheswari, N.; Panda, N.B.; Mahajan, S.; Luthra, A.; Pattnaik, S.; Bhatia, N.; Karthigeyan, M.; Kaloria, N.; Chauhan, R.; Soni, S.; Jangra, K.; Bhagat, H. Ketofol as an Anesthetic Agent in Patients With Isolated Moderate to Severe Traumatic Brain Injury: A Prospective, Randomized Double-blind Controlled Trial. J. Neurosurg. Anesthesiol. 2023, 35(1), 49-55. DOI: 10.1097/ANA.0000000000000774.
DOI: https://doi.org/10.1097/ANA.0000000000000774
Biliškov, A.N.; Ivančev, B.; Pogorelić, Z. Effects on Recovery of Pediatric Patients Undergoing Total Intravenous Anesthesia with Propofol versus Ketofol for Short-Lasting Laparoscopic Procedures. Children (Basel) 2021, 8(7), Art. No: 610. DOI: 10.3390/children8070610.
DOI: https://doi.org/10.3390/children8070610
Strayer, R.J. Current concepts in ketamine therapy in the emergency department. Emerg. Med. Pract. 2024, 26(5), 1-24.
García-Ruiz, M.; Rodríguez, P.M.; Palliotti, L.; Lastras, C.; Romeral-Jiménez, M.; Morales, I.G.; Rey, C.P.; Rodrigo-Gisbert, M.; Campos-Fernández, D.; Santamarina, E.; Carbonell, B.P. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres. Seizure 2024, 117, 13-19. DOI: 10.1016/j.seizure.2024.01.013.
DOI: https://doi.org/10.1016/j.seizure.2024.01.013
Buratti, S.; Giacheri, E.; Palmieri, A.; Tibaldi, J.; Brisca, G.; Riva, A.; Striano, P.; Mancardi, M.M.; Nobili, L.; Moscatelli, A. Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children. Epilepsia 2023, 64(4), 797-810. DOI: 10.1111/epi.17550.
DOI: https://doi.org/10.1111/epi.17550
Espinosa, L.; Gomez, M.; Zamora, A.; Molano-Franco, D. Refractory and super-refractory status epilepticus and evidence for the use of ketamine: a scope review. J. Neurocrit. Care 2023, 16(1), 1-9. DOI: 10.18700/jnc.230003.
DOI: https://doi.org/10.18700/jnc.230003
Heuser, K.; Olsen, K.B.; Ulvin, L.B.; Gjerstad, L.; Erik Taubøll, E. Modern Treatment of Status Epilepticus in Adults. In: Czuczwar SJ, editor. Epilepsy [Internet]. Brisbane (AU): Exon Publications; 2022 Apr 2. Chapter 5. Available online: https://www.ncbi.nlm.nih.gov/books/NBK580620/ DOI: 10.36255/exon-publications-epilepsy-status-epilepticus.
DOI: https://doi.org/10.36255/exon-publications-epilepsy-status-epilepticus
Besha, A.; Adamu, Y.; Mulugeta, H.; Zemedkun, A.; Destaw, B. Evidence-based guideline on management of status epilepticus in adult intensive care unit in resource-limited settings: a review article. Ann. Med. Surg. (Lond.) 2023, 85(6), 2714-2720. DOI: 10.1097/MS9.0000000000000625.
DOI: https://doi.org/10.1097/MS9.0000000000000625
What is the role of ketamine in the management of status epilepticus? Available online: https://dig.pharmacy.uic.edu/faqs/2023-2/december-2023-faqs/what-is-the-role-of-ketamine-in-the-management-of-status-epilepticus/ (accessed on 29.06.2024).
Williams, N.C.; Morgan, L.A.; Friedman, J.; Siegler, J. Ketamine Efficacy for Management of Status Epilepticus: Considerations for Prehospital Clinicians. Air Med. J. 2024, 43(2), 84-89. DOI: 10.1016/j.amj.2023.09.011.
DOI: https://doi.org/10.1016/j.amj.2023.09.011
Jacobwitz, M.; Mulvihill, C.; Kaufman, M.C.; Gonzalez, A.K.; Resendiz, K.; MacDonald, J.M.; Francoeur, C.; Helbig, I.; Topjian, A.A.; Abend, N.S. Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. Neurology 2022, 99(12), e1227-e1238. DOI: 10.1212/WNL.0000000000200889.
DOI: https://doi.org/10.1212/WNL.0000000000200889
Van de Voorde, P.; Turner, N.M.; Djakow, J.; de Lucas, N.; Martinez-Mejias, A.; Biarent, D.; Bingham, R., Brissaud, O.; Hoffmann, F.; Johannesdottirl, G.B.; Lauritsen, T.; Maconochie, I. European Resuscitation Council Guidelines 2021: Paediatric Life Support. Resuscitation 2021, 161, 327-387. DOI: 10.1016/j.resuscitation.2021.02.015
DOI: https://doi.org/10.1016/j.resuscitation.2021.02.015
Chakraborty, R.K.; Chen, R.J.; Basnet, S. Status Asthmaticus. 2024 Feb 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. Available online: https://www.ncbi.nlm.nih.gov/books/NBK526070/ (accessed on 29.06.2024).
Garner, O.; Ramey, J.S.; Hanania, N.A. Management of Life-Threatening Asthma: Severe Asthma Series. Chest 2022, 162(4), 747-756. DOI: 10.1016/j.chest.2022.02.029.
DOI: https://doi.org/10.1016/j.chest.2022.02.029
La Via, L.; Sanfilippo, F.; Cuttone, G.; Dezio, V.; Falcone, M.; Brancati, S.; Crimi, C.; Astuto, M. Use of ketamine in patients with refractory severe asthma exacerbations: systematic review of prospective studies. Eur. J. Clin. Pharmacol. 2022, 78, 1613–1622. DOI: https://doi.org/10.1007/s00228-022-03374-3.
DOI: https://doi.org/10.1007/s00228-022-03374-3
Nedel, W.; Costa, R.; Mendez, G.; Marin, L.; Vargas, T.; Marques, L. Negative results for ketamine use in severe acute bronchospasm: a randomised controlled trial. Anaesthesiol. Intensive Ther. 2020, 52(3), 215-218. DOI: 10.5114/ait.2020.97765.
DOI: https://doi.org/10.5114/ait.2020.97765
Simon, E.L.; Smalley, C.M.; Muir, M.; Mangira, C.M.; Pence, R.; Wahi-Singh, B.; Delgado, F.; Fertel, B.S. Agitation Management in the Emergency Department with Physical Restraints: Where Do These Patients End Up? West J. Emerg. Med. 2023, 24(3), 454-460. DOI: 10.5811/westjem.59466.
DOI: https://doi.org/10.5811/WESTJEM.59466
Corwell, B.N.; Motov, S.M.; Davis, N.L.; Kim, H.K. Novel uses of ketamine in the emergency department. Expert Opin. Drug Saf. 2022, 21(8), 1009-1025. DOI: 10.1080/14740338.2022.2100883.
DOI: https://doi.org/10.1080/14740338.2022.2100883
Curry, A.; Malas, N.; Mroczkowski, M.; Hong, V. Nordstrom K.; Terrell C. Updates in the Assessment and Management of Agitation. Focus (Am. Psychiatr. Publ.) 2023, 21(1), 35-45. DOI: 10.1176/appi.focus.20220064
DOI: https://doi.org/10.1176/appi.focus.20220064
Barbic, D.; Andolfatto, G.; Grunau, B.; Scheuermeyer, F.X.; Macewan, B.; Qian, H.; Wong, H.; Barbic, S.P; Honer, W.G. Rapid Agitation Control With Ketamine in the Emergency Department: A Blinded, Randomized Controlled Trial. Ann. Emerg. Med. 2021, 78(6), 788-795. DOI: 10.1016/j.annemergmed.2021.05.023.
DOI: https://doi.org/10.1016/j.annemergmed.2021.05.023
Lin, J.; Figuerado, Y.; Montgomery, A.; Lee, J.; Cannis, M.; Norton, V.C.; Calvo, R.; Sikand, H. Efficacy of ketamine for initial control of acute agitation in the emergency department: A randomized study. Am. J. Emerg. Med. 2021, 44, 306-311. DOI: 10.1016/j.ajem.2020.04.013.
DOI: https://doi.org/10.1016/j.ajem.2020.04.013
Kim, H. K.; Leonard, J. B.; Corwell, B. N.; Connors, N. J. Safety and efficacy of pharmacologic agents used for rapid tranquilization of emergency department patients with acute agitation or excited delirium. Expert Opin. Drug Saf. 2021, 20(2), 123–138. DOI: 10.1080/14740338.2021.1865911.
DOI: https://doi.org/10.1080/14740338.2021.1865911
Garel, N.; McAnulty, C.; Greenway, K.T.; Lesperance, P.; Miron, J.P.; Rej, S.; Richard-Devantoy, S.; Jutras-Aswad, D. Efficacy of ketamine intervention to decrease alcohol use, cravings, and withdrawal symptoms in adults with problematic alcohol use or alcohol use disorder: A systematic review and comprehensive analysis of mechanism of actions. Drug Alcohol Depend. 2022, 239, Art. No: 109606. DOI:10.1016/j.drugalcdep.2022.109606.
DOI: https://doi.org/10.1016/j.drugalcdep.2022.109606
Goldfine, C.E.; Tom, J.J.; Im, D.D.; Yudkoff, B.; Anand, A.; Taylor, J.J.; Chai, P.R; Suzuki, J. The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review. Front. Psychiatry 2023, 14, Art. No: 1141836. DOI: 10.3389/fpsyt.2023.1141836.
DOI: https://doi.org/10.3389/fpsyt.2023.1141836
Kelson, M.; Burnett, J.M.; Matthews, A.; Juneja, T. Ketamine Treatment for Alcohol Use Disorder: A Systematic Review. Cureus 2023, 15(5), Art. No: e38498. DOI: 10.7759/cureus.38498.
DOI: https://doi.org/10.7759/cureus.38498
Tran, K.; MacDougall, D. Ketamine for Adults With Substance Use Disorders: Rapid Review [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Feb. Available online: https://www.ncbi.nlm.nih.gov/books/NBK602506/ (accessed on 29.06.2024)
Sajid, S.; Lawrence, R.E.; Galfalvy, H.C.; Keilp, J.G.; Moitra, V.K.; Mann, J.J.; Grunebaum, M.F. Intramuscular ketamine vs. midazolam for rapid risk-reduction in suicidal, depressed emergency patients: Clinical trial design and rationale. J. Affect. Disord. Rep. 2024, 15, Art. No: 100690. DOI: 10.1016/j.jadr.2023.100690.
DOI: https://doi.org/10.1016/j.jadr.2023.100690
Whitaker, T.; Farrand, K.F.; Thase, M.E. A Phase 2 Open Label Study of Efficacy, Safety, and Tolerability of SLS-002 (Intranasal Racemic Ketamine) in Adults with MDD at Imminent Risk of Suicide. Psychopharmacol. Bull. 2024, 54(1), 8-17.
Kumari, S.; Chaudhry, H.A.; Sagot, A.; Doumas, S.; Abdullah, H.; Alcera, E.; Solhkhah, R.; Afzal, S. Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review. Cureus 2024, 16(2), Art. No: e53987. DOI: 10.7759/cureus.53987.
DOI: https://doi.org/10.7759/cureus.53987
Anzolin, A.P.; Baldez, D.P.; Montezano, B.B.; Kapczinski, F.; de Abreu, P.B.; Kauer-Sant'Anna, M. Subcutaneous ketamine reduces suicide risk and improves functioning in depression: A proof-of-concept study. Psychiatry Res. 2024, 337. Art. No: 115915. DOI: 10.1016/j.psychres.2024.115915.
DOI: https://doi.org/10.1016/j.psychres.2024.115915
Shen, Z.; Gao, D.; Lv, X.; Wang, H.; Yue W. A meta-analysis of the effects of ketamine on suicidal ideation in depression patients. Transl. Psychiatry 2024, 14(1), Art. No: 248. DOI: 10.1038/s41398-024-02973-1.
DOI: https://doi.org/10.1038/s41398-024-02973-1
Zolghadriha, A.; Anjomshoaa, A.; Jamshidi, M.R.; Taherkhani, F. Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial. BMC Psychiatry 2024, 24(1), Art. No: 341. DOI: 10.1186/s12888-024-05716-0.
DOI: https://doi.org/10.1186/s12888-024-05716-0
Wang, Y.T.; Wang, X.L.; Lei, L.; Guo, Z.Y.; Kan, F.F.; Hu, D.; Gai, C.; Zhang, Y. A systematic review and meta-analysis of the efficacy of ketamine and esketamine on suicidal ideation in treatment-resistant depression. Eur. J. Clin. Pharmacol. 2024, 80(2), 287-296. DOI: 10.1007/s00228-023-03605-1.
DOI: https://doi.org/10.1007/s00228-023-03605-1
McIntyre, R.S.; Mansur, R.B.; Rosenblat, J.D.; Teopiz, K.M.; Kwan, A.T.H. The association between ketamine and esketamine and suicidality: reports to the Food And Drug Administration Adverse Event Reporting System (FAERS). Expert Opin. Drug Saf. 2024, 1-6. DOI: 10.1080/14740338.2024.2368827.
DOI: https://doi.org/10.1080/14740338.2024.2368827
Bruton, A.M.; Wesemann, D.G.; Machingo, T.A.; Majak, G.; Johnstone, J.M.; Marshall, R.D. Ketamine for mood disorders, anxiety, and suicidality in children and adolescents: a systematic review. Eur. Child Adolesc. Psychiatry 2024. DOI: 10.1007/s00787-024-02458-y.
DOI: https://doi.org/10.1007/s00787-024-02458-y
Emslie, G.J. Editorial: Novel Approaches to the Treatment of Suicidality and Depression in Youth. J. Am. Acad. Child Adolesc. Psychiatry 2024, 63(5), 500-501. DOI: 10.1016/j.jaac.2023.06.019.
DOI: https://doi.org/10.1016/j.jaac.2023.06.019
Seshadri, A.; Prokop, L.J.; Singh, B. Efficacy of intravenous ketamine and intranasal esketamine with dose escalation for Major depression: A systematic review and meta-analysis. J. Affect. Disord. 2024, 356, 379-384. DOI: 10.1016/j.jad.2024.03.137.
DOI: https://doi.org/10.1016/j.jad.2024.03.137
English
Język Polski
